These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8152930)
1. Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3'hydroxypropylamine oligonucleotide. Tam RC; Li Y; Noonberg S; Hwang DG; Lui G; Hunt CA; Garovoy MR Nucleic Acids Res; 1994 Mar; 22(6):977-86. PubMed ID: 8152930 [TBL] [Abstract][Full Text] [Related]
2. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Gao WY; Han FS; Storm C; Egan W; Cheng YC Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582 [TBL] [Abstract][Full Text] [Related]
3. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. Monia BP; Johnston JF; Sasmor H; Cummins LL J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854 [TBL] [Abstract][Full Text] [Related]
4. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. Chin DJ; Green GA; Zon G; Szoka FC; Straubinger RM New Biol; 1990 Dec; 2(12):1091-100. PubMed ID: 1708281 [TBL] [Abstract][Full Text] [Related]
5. Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H. Koziolkiewicz M; Krakowiak A; Kwinkowski M; Boczkowska M; Stec WJ Nucleic Acids Res; 1995 Dec; 23(24):5000-5. PubMed ID: 8559657 [TBL] [Abstract][Full Text] [Related]
6. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Temsamani J; Kubert M; Tang J; Padmapriya A; Agrawal S Antisense Res Dev; 1994; 4(1):35-42. PubMed ID: 8061514 [TBL] [Abstract][Full Text] [Related]
7. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications. Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728 [TBL] [Abstract][Full Text] [Related]
8. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Akhtar S; Kole R; Juliano RL Life Sci; 1991; 49(24):1793-801. PubMed ID: 1943483 [TBL] [Abstract][Full Text] [Related]
9. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Yaida Y; Nowak TS Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754 [TBL] [Abstract][Full Text] [Related]
10. Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells. Vivès E; Dell'Aquila C; Bologna JC; Morvan F; Rayner B; Imbach JL Nucleic Acids Res; 1999 Oct; 27(20):4071-6. PubMed ID: 10497272 [TBL] [Abstract][Full Text] [Related]
11. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Iversen PL; Zhu S; Meyer A; Zon G Antisense Res Dev; 1992; 2(3):211-22. PubMed ID: 1490072 [TBL] [Abstract][Full Text] [Related]
12. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Thierry AR; Dritschilo A Nucleic Acids Res; 1992 Nov; 20(21):5691-8. PubMed ID: 1454532 [TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. Crooke RM; Graham MJ; Cooke ME; Crooke ST J Pharmacol Exp Ther; 1995 Oct; 275(1):462-73. PubMed ID: 7562586 [TBL] [Abstract][Full Text] [Related]
14. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15. Nakai D; Seita T; Terasaki T; Iwasa S; Shoji Y; Mizushima Y; Sugiyama Y J Pharmacol Exp Ther; 1996 Sep; 278(3):1362-72. PubMed ID: 8819524 [TBL] [Abstract][Full Text] [Related]
15. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition. Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767 [TBL] [Abstract][Full Text] [Related]
16. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35]. Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358 [TBL] [Abstract][Full Text] [Related]
17. Binding of nuclear factors to the IFN-gamma consensus sequence of the human HLA-DR alpha gene: effects of IFN-gamma on tumor cell lines. Gambari R; Barbieri R; Nastruzzi C; Feriotto G; Piva R; Natali PG; Giacomini P J Biol Regul Homeost Agents; 1990; 4(3):98-106. PubMed ID: 2135380 [TBL] [Abstract][Full Text] [Related]
18. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Marcusson EG; Bhat B; Manoharan M; Bennett CF; Dean NM Nucleic Acids Res; 1998 Apr; 26(8):2016-23. PubMed ID: 9518498 [TBL] [Abstract][Full Text] [Related]
19. Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake. Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J Antisense Res Dev; 1995; 5(3):193-201. PubMed ID: 8785475 [TBL] [Abstract][Full Text] [Related]
20. Uptake dynamics and retinal tolerance of phosphorothioate oligonucleotide and its direct delivery into the site of choroidal neovascularization through subretinal administration in the rat. Shen WY; Rakoczy PE Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):257-64. PubMed ID: 11572602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]